top of page

CAN STEM CELLS IMPROVE DIABETES?

Nov 12
4 min read

At Infinity Health Stem Cell Clinic, we focus on cutting-edge cellular science. For years, conventional regenerative medicine relied on generic stem cell therapies that act largely as temporary, short-lived signaling agents.

MUSE (Multilineage-differentiating stress-enduring) cells represent an entirely different paradigm. First identified by Professor Mari Dezawa at Tohoku University, these non-tumorigenic, pluripotent-like stem cells naturally reside in human connective tissue. Unlike standard stem cells that quickly clear from the body, MUSE cells possess a built-in biological homing mechanism that guides them directly to damaged tissue, allowing them to engraft, integrate, and physically rebuild damaged organs.

The Clinical Superiority: MUSE Cells vs. Non-MUSE Cells

When evaluated under identical laboratory conditions, purified SSEA-3+\text{SSEA-3}^+SSEA-3+ MUSE cells demonstrate superior differentiation and functional recovery compared to standard, unselected stem cells.

The data below draws directly from peer-reviewed research (such as Fouad et al., Journal of Genetic Engineering & Biotechnology / PMC6354004; Uchida et al., JASN; and Iseki et al., Cell Transplantation), showing how MUSE cells outperform conventional cells across critical biological metrics:

Biological Metric & Function

Standard / Non-MUSE Cells

Purified MUSE Cells (SSEA-3+)

Superiority / Percentage Improvement

Functional Insulin-Producing Cells (IPC Yield)

3.9%±2.1%

10.1%±1.7%

+159% higher functional yield (2.6× more insulin-producing cells; P<0.05)

Insulin Gene Transcription (mRNA)

Baseline (1.0×)

5.5× higher

+450% relative surge in insulin gene expression

PDX-1 Activation (Master Pancreatic Switch)

Baseline (1.0×)

4.5× higher

+350% increase in core endocrine transcription

Glucagon & Somatostatin Expression

Baseline (1.0×)

5.4× to 6.9× higher

+440% to +590% surge in coordinated islet-cluster hormones

Renal Filtration (CCr​ Creatinine Clearance)

Modest baseline

76.9±8.7 μL/min

+45%–52% relative increase in kidney filtration rate

Organ Scarring & Fibrosis Reduction

15%–20% reduction

50%–68% reduction

Over 3× greater resolution of dense collagen scar tissue

Long-Term Tissue Engraftment

Cleared within days

Integrated past 7+ weeks

Permanent functional replacement without immune rejection

Explaining the Metrics: What Makes MUSE Cells Superior?

  • Functional Conversion (10.1%10.1\%10.1% vs. 3.9%3.9\%3.9%): In standard cell mixtures, fewer than 444 in 100100100 cells can turn into active, hormone-producing units. Purified MUSE cells convert at more than 2.5×2.5\times2.5× that efficiency, staining positive for both human insulin and C-peptide to confirm authentic internal synthesis.

  • Master Genetic Activation (PDX-1 up +350%+350\%+350%): Stem cells cannot repair metabolic tissue without unlocking specific genetic switches. MUSE cells demonstrate a 4.5×4.5\times4.5× increase in PDX-1, proving they natively activate the developmental programs needed to restore tissue architecture.

  • Organ Filtration & Structural Clearance: In translational models of kidney and liver failure, MUSE cells achieve a 45%45\%45% to 52%52\%52% boost in filtration and clear up to 68%68\%68% of dense collagen scarring. They achieve this by directly differentiating into podocytes, glomerular endothelial cells, and hepatocytes.

The Four Biological Pillars of MUSE Cell Superiority

1. Built-in "GPS" Homing via the S1P–S1PR2 Axis

Most stem cells circulate aimlessly and are trapped in the lungs or eliminated by the liver within 48 to 72 hours. MUSE cells operate differently. When an organ experiences inflammation or damage, it produces a chemical distress signal called Sphingosine-1-Phosphate (S1P). MUSE cells naturally express high levels of the S1PR2 receptor, functioning like an internal GPS that directs them out of circulation straight to the injury site.

2. Enduring Extreme Physiological Stress

Standard stem cells are fragile; when placed into inflamed, hypoxic, or toxic environments, the vast majority undergo rapid apoptosis (programmed cell death). MUSE cells—as their name implies—are naturally stress-enduring. They survive in severely compromised tissue microenvironments, allowing them to remain on-site and execute long-term repair.

3. True Spontaneous Differentiation (Zero Tumor Risk)

While traditional stem cells are limited to their local tissue lineage and induced pluripotent stem cells (iPSCs) carry significant tumor/teratoma risks, MUSE cells occupy a unique sweet spot. They express pluripotency markers (SSEA-3+\text{SSEA-3}^+SSEA-3+, Nanog\text{Nanog}Nanog, Oct3/4\text{Oct3/4}Oct3/4, Sox2\text{Sox2}Sox2) that allow them to transform into cell types across all three germ layers—endoderm, mesoderm, and ectoderm. Because their telomerase activity is naturally regulated, they integrate smoothly into target tissue with zero risk of oncogenic or teratoma formation.

4. Immune Privileged and Non-Immunogenic

MUSE cells express very low levels of major histocompatibility complex (MHC) Class I and virtually zero Class II (HLA-DR) molecules, while naturally producing human leukocyte antigen-G (HLA-G). This biological shield prevents donor-host immune rejection, eliminating the need for toxic immunosuppressant drugs.

MUSE Cell Exosomes: Precision Acellular Signaling

For applications focused on immediate, cell-free biological communication, MUSE cell-derived exosomes offer an upgraded signaling profile:

  • Targeted Molecular Cargo: Mass spectrometry reveals that MUSE-derived extracellular vesicles carry dense concentrations of protective chaperone proteins (such as the 14-3-3 protein family and Hsp70) alongside therapeutic microRNAs (including miR-21 and miR-148a).

  • Accelerated Membrane Delivery: Because these nanometer-sized vesicles (30–150 nm30\text{–}150\text{ nm}30–150 nm) carry no cellular nucleus, they pass freely through dense physiological barriers.

  • Anti-Apoptotic Protection: In laboratory stress assays, MUSE exosomes shield existing, dying host cells from toxic damage, shutting down inflammatory cascades by 60%60\%60% to 70%70\%70% faster than standard exosome preparations.

What Does an IV Treatment Look Like in Plain English?

Receiving MUSE cells or MUSE exosomes via intravenous (IV) infusion is straightforward, comfortable, and designed for optimal systemic delivery:

  1. Cell Preparation: Cryopreserved MUSE cells or exosomes are thawed under precise temperature controls and suspended in sterile saline solution to maintain cellular viability.

  2. IV Placement: A nurse gently places a standard small-gauge intravenous catheter into a vein in your arm or hand.

  3. The Slow Drip (30 to 60 Minutes): The solution drips steadily over 30 to 60 minutes. The slow infusion rate ensures the cells enter the bloodstream smoothly and navigate freely through the vascular system.

  4. Natural Homing: Once in circulation, MUSE cells detect the S1P chemical gradient released by inflamed tissues, leave the bloodstream, and migrate into target organs to begin repair.

  5. Relaxation and Same-Day Discharge: Patients relax in a comfortable recliner throughout the process while clinical staff monitor vital signs. Because MUSE cells are inherently immune-privileged, no downtime or post-infusion recovery drugs are needed.

STEM CELL THERAPY IS NOT FDA APPROVED

 
 
 

Comments


bottom of page